Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Dronabinol market size was valued at USD 153.4 Million in 2022 and will reach USD 337.83 Million in 2028, with a CAGR of 14.06% during 2022-2028.
Dronabinol is an active cannabinoid. The molecular formula is C21H30O2, the molecular weight is 314.46200, the boiling point is 155~157℃ (6.7Pa), and the optical rotation is -156 (c=0.34, ethanol). Dronabinol is an antiemetic drug, which is mainly used clinically for nausea and vomiting caused by chemotherapy in cancer patients.
Market Drivers and Impact
US
In 2016, the U.S. Food and Drug Administration (FDA) has approved Insys' dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol. The FDA's approval of Syndros may be indicative of a growing movement toward accepting synthetic
forms of marijuana to treat different health issues. With the advancement of the legalization of dronabinol medical policy in the United States, the market demand for dronabinol in the United States will gradually increase.
Canadian
Dronabinol is an active cannabinoid. According to the purpose and function, countries around the world mainly divide cannabis decrees into two categories: recreational use and medical use, and there are corresponding regulations for the cultivation of industrial hemp. On the afternoon of June 20, 2018, Canada passed Bill C-45 (Cannabis Act), officially announcing that Cannabis will be legalized on October 17, becoming the second country since Uruguay to legalize recreational Cannabis. Both recreational and medical Cannabis are legal in Canada after passing the Cannabis Act. These policies have led to increased demand for Dronabinol in the market.
Growing Demand from Key Applications and Potential Industries
Dronabinol, also known as Δ9 -THC, is one of the main active substances in cannabis. THC e-cigarettes also occupy a certain market in e-cigarettes. E-cigarette use among young people has
skyrocketed in recent years and remains at epidemic levels: about one in five high school students used e-cigarettes in 2020, many of whom were not smokers in the first place. In the USA, the 2020 National Youth Tobacco Survey data show that 38.9% of current high school e-cigarette users use e-cigarettes on 20 days or more per month, up from 34.2% in 2019. This shows that e-cigarettes will become a potential development market.
Region Overview:
North America was the largest revenue market with a market share of 67.61% in 2016 and 67.98%
in 2021, an increase of 0.37%. In 2021, the Europe market share was 22.11%, ranking second. In
addition, Asia Pacific Dronabinol market is expected to be the growing market.
Company Overview:
The top three companies are Canopy Growth, Noramco, Benuvia Manufacturing with the revenue market share of 32.11%, 8.93%, 5.06% in 2021.
Canopy Growth
Canopy Growth Corporation engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.
Noramco
Headquartered in Wilmington, Delaware, Noramco is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat Attention Deficit Hyperactivity Disorder, pain, addiction, and for abuse-deterrent formulations.
Segmentation Overview:
Among different product types, 98% segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Capsule segment occupied the biggest share from 2017 to 2022.
Capsule
Capsule basically refers to Dronabinol wrapped in a relatively stable shell for oral administration or as a suppository.
Oral Liquid
Oral solutions are homogeneous liquid preparations, usually consisting of a solution, emulsion or suspension of one or more active ingredients in a suitable liquid matrix. They are prepared for oral administration as such or diluted.
The Dronabinol market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Dronabinol market covered in Chapter 4:
Echo Pharmaceuticals
Benuvia Manufacturing
Canopy Growth
BOL Pharma acturing
Noramco
In Chapter 12 and Chapter 14.1, on the basis of types, the Dronabinol market from 2018 to 2028 is primarily split into:
98%
99%
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Dronabinol market from 2018 to 2028 covers:
Capsule
Oral Liquid
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Dronabinol market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Dronabinol market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Dronabinol industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Dronabinol industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Dronabinol market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Dronabinol market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Dronabinol market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Dronabinol market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Dronabinol is an active cannabinoid. The molecular formula is C21H30O2, the molecular weight is 314.46200, the boiling point is 155~157℃ (6.7Pa), and the optical rotation is -156 (c=0.34, ethanol). Dronabinol is an antiemetic drug, which is mainly used clinically for nausea and vomiting caused by chemotherapy in cancer patients.
Market Drivers and Impact
US
In 2016, the U.S. Food and Drug Administration (FDA) has approved Insys' dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol. The FDA's approval of Syndros may be indicative of a growing movement toward accepting synthetic
forms of marijuana to treat different health issues. With the advancement of the legalization of dronabinol medical policy in the United States, the market demand for dronabinol in the United States will gradually increase.
Canadian
Dronabinol is an active cannabinoid. According to the purpose and function, countries around the world mainly divide cannabis decrees into two categories: recreational use and medical use, and there are corresponding regulations for the cultivation of industrial hemp. On the afternoon of June 20, 2018, Canada passed Bill C-45 (Cannabis Act), officially announcing that Cannabis will be legalized on October 17, becoming the second country since Uruguay to legalize recreational Cannabis. Both recreational and medical Cannabis are legal in Canada after passing the Cannabis Act. These policies have led to increased demand for Dronabinol in the market.
Growing Demand from Key Applications and Potential Industries
Dronabinol, also known as Δ9 -THC, is one of the main active substances in cannabis. THC e-cigarettes also occupy a certain market in e-cigarettes. E-cigarette use among young people has
skyrocketed in recent years and remains at epidemic levels: about one in five high school students used e-cigarettes in 2020, many of whom were not smokers in the first place. In the USA, the 2020 National Youth Tobacco Survey data show that 38.9% of current high school e-cigarette users use e-cigarettes on 20 days or more per month, up from 34.2% in 2019. This shows that e-cigarettes will become a potential development market.
Region Overview:
North America was the largest revenue market with a market share of 67.61% in 2016 and 67.98%
in 2021, an increase of 0.37%. In 2021, the Europe market share was 22.11%, ranking second. In
addition, Asia Pacific Dronabinol market is expected to be the growing market.
Company Overview:
The top three companies are Canopy Growth, Noramco, Benuvia Manufacturing with the revenue market share of 32.11%, 8.93%, 5.06% in 2021.
Canopy Growth
Canopy Growth Corporation engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.
Noramco
Headquartered in Wilmington, Delaware, Noramco is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat Attention Deficit Hyperactivity Disorder, pain, addiction, and for abuse-deterrent formulations.
Segmentation Overview:
Among different product types, 98% segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Capsule segment occupied the biggest share from 2017 to 2022.
Capsule
Capsule basically refers to Dronabinol wrapped in a relatively stable shell for oral administration or as a suppository.
Oral Liquid
Oral solutions are homogeneous liquid preparations, usually consisting of a solution, emulsion or suspension of one or more active ingredients in a suitable liquid matrix. They are prepared for oral administration as such or diluted.
The Dronabinol market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Dronabinol market covered in Chapter 4:
Echo Pharmaceuticals
Benuvia Manufacturing
Canopy Growth
BOL Pharma acturing
Noramco
In Chapter 12 and Chapter 14.1, on the basis of types, the Dronabinol market from 2018 to 2028 is primarily split into:
98%
99%
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Dronabinol market from 2018 to 2028 covers:
Capsule
Oral Liquid
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Dronabinol market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Dronabinol market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Dronabinol industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Dronabinol industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Dronabinol market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Dronabinol market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Dronabinol market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Dronabinol market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
